Whole genome sequencing analysis of Mycobacterium tuberculosis reveals circulating strain types and drug-resistance mutations in the Philippines
Authors:
Open Access
- 23 August 2024
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-11
Abstract
The Philippines is a high-incidence country for tuberculosis, with the increasing prevalence of multi- (MDR-TB) and extensively-drug (XDR-TB) resistant Mycobacterium tuberculosis strains posing difficulties to disease control. Understanding the genetic diversity of circulating strains can provide insights into underlying drug resistance mutations and transmission dynamics, thereby assisting the design of diagnostic tools, including those using next generation sequencing (NGS) platforms. By analysing genome sequencing data of 732 isolates from Philippines drug-resistance survey collections spanning from 2011 to 2019, we found that the majority belonged to lineages L1 (531/732; 72.5%) and L4 (European-American; n = 174; 23.8%), with the Manila strain (L1.2.1.2.1) being the most prominent (475/531). Approximately two-thirds of isolates were found to be at least MDR-TB (483/732; 66.0%), and potential XDR-TB genotypic resistance was observed (3/732; 0.4%), highlighting an emerging problem in the country. Genotypic resistance was highly concordant with laboratory drug susceptibility testing. By finding isolates with (near-)identical genomic variation, five major clusters containing a total of 114 isolates were identified: all containing either L1 or L4 isolates with at least MDR-TB resistance and spanning multiple years of collection. Closer inspection of clusters revealed transmission in prisons, some involving isolates with XDR-TB, and mutations linked to third-line drug bedaquiline. We have also identified previously unreported mutations linked to resistance for isoniazid, rifampicin, ethambutol, and fluoroquinolones. Overall, this study provides important insights into the genetic diversity, transmission and circulating drug resistance mutations of M. tuberculosis in the Philippines, thereby informing clinical and surveillance decision-making, which is increasingly using NGS platforms.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/T008709/1)
- Medical Research Council,United Kingdom (MR/N010469/1, MR/N010469/1)
- Engineering and Physical Sciences Research Council (EP/Y018842/1, EP/Y018842/1)
- British Council (261868591)
This publication has 36 references indexed in Scilit:
- Comparison of in silico predicted Mycobacterium tuberculosis spoligotypes and lineages from whole genome sequencing dataScientific Reports, 2023
- Phylogeography and transmission of Mycobacterium tuberculosis spanning prisons and surrounding communities in ParaguayNature Communications, 2023
- Prisoner’s dilemma game model Based on historical strategy informationScientific Reports, 2023
- Molecular characterization of drug-resistant Mycobacterium tuberculosis among Filipino patients derived from the national tuberculosis prevalence survey Philippines 2016Tuberculosis, 2022
- Characterisation of drug-resistant Mycobacterium tuberculosis mutations and transmission in PakistanScientific Reports, 2022
- Mycobacterium tuberculosis whole genome sequencing provides insights into the Manila strain and drug-resistance mutations in the PhilippinesScientific Reports, 2019
- XDR-TB transmission in London: Case management and contact tracing investigation assisted by early whole genome sequencingJournal of Infection, 2016
- rrs and rpsL mutations in streptomycin-resistant isolates of Mycobacterium tuberculosis from MexicoJournal of Microbiology, Immunology and Infection, 2013
- Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathwayJournal of Proteomics, 2011
- The Mycobacterium tuberculosis cytochrome P450 systemArchives of Biochemistry and Biophysics, 2010